首页> 外文期刊>Interventional neuroradiology: journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences >Safety and efficacy of the use of large bore intermediate suction catheters alone or in combination for the treatment of acute cerebral venous sinus thrombosis: A multicenter experience
【24h】

Safety and efficacy of the use of large bore intermediate suction catheters alone or in combination for the treatment of acute cerebral venous sinus thrombosis: A multicenter experience

机译:使用大型孔中间吸毒导管的安全性和功效,或组合治疗急性脑静脉窦血栓形成:多中心经验

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background and purpose:Systemic anticoagulation is the standard treatment for cerebral venous sinus thrombosis (CVST). Several endovascular techniques have been described as salvage therapy for anticoagulation refractory CVST cases. We aim to evaluate the safety and feasibility of endovascular aspiration thrombectomy using the new generation, large bore suction catheters alone or in combination with stentriever devices for the treatment of CVST.Methods:We collected data on 16 consecutive patients with CVST who received endovascular aspiration thrombectomy at three large academic centers. Second generation reperfusion catheters were used as a large bore suction catheter and advanced to the affected sinus using a coaxial technique. Suction was performed using pump suction. At times, a stentriever was used as an anchor to facilitate advancing the suction catheter and to increase thrombectomy capabilities.Results:Median decade of age was the 50s and nine patients were women. Fifty percent of the patients had multiple sinuses involved. All patients received systemic anticoagulation prior to endovascular aspiration thrombectomy. The most common reason to pursue endovascular aspiration thrombectomy in CVST patients was deterioration of initial clinical status (10/16). The mean time from admission to endovascular aspiration thrombectomy was 1.5 days (range 0-6 days). Good recanalization was obtained in all patients. There were no major peri-procedural complications. Most patients were discharged to either home or a rehabilitation facility.Conclusion:Endovascular aspiration treatment using large bore suction catheters for CVST is a safe and feasible approach for the treatment of anticoagulation refractory CVST. Heterogeneity of the clinical and radiological presentation requires further investigation to optimize patient selection before evaluating the efficacy of this technique in larger prospective studies.
机译:背景论:系统抗凝是脑静脉血栓形成(CVST)的标准治疗方法。已经描述了几种血管内技术作为抗凝难治性CVST病例的救助疗法。我们的目标是使用新一代,单独的大型钻孔抽吸导管或与Stentriever装置的治疗方法进行血管内吸入血栓切除术的安全性和可行性,用于治疗CVST.Methods:我们在接受血管内吸入血栓切除术的CVST连续16名患者收集数据在三个大型学术中心。第二代再灌注导管用作大孔吸盘导管,并使用同轴技术前进到受影响的窦。使用泵抽吸进行抽吸。有时,用作锚的锚定,以便于推进吸毒导管并增加血液切除术能力。结果:中位数年龄是50岁和9名患者是女性。 50%的患者涉及多个鼻窦。所有患者在血管内吸入血液切除术之前接受全身抗凝。在CVST患者中寻求血管内吸入血栓切除术的最常见原因是初始临床状态的恶化(10/16)。入学到血管内吸入血液切除术的平均时间为1.5天(0-6天)。在所有患者中获得了良好的再生化。没有重大的Peri-properation杂志。大多数患者被排放到家庭或康复设施中。结论:使用大孔抽吸导管用于CVST的血管内抽吸治疗是治疗抗凝耐火CVST的安全和可行的方法。临床和放射介绍的异质性需要进一步调查,以便在评估该技术在更大的前瞻性研究中的功效之前优化患者选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号